Gastrointestinal Cancer Drug Market Globally Expected to Drive Growth [+Net Income] | 2022-2031
The gastrointestinal cancer drug market is forecast to reach USD 17.8 billion by 2025, driven by the rising incidence of gastrointestinal cancers and the availability of new, targeted therapies. Gastrointestinal cancers are the fourth most common type of cancer worldwide, with an estimated 1.3 million new cases diagnosed each year. The majority of gastrointestinal cancers are adenocarcinomas, which develop in the lining of the stomach or intestines. Other less common types include neuroendocrine tumors, lymphomas, and sarcomas. The most common symptom of gastrointestinal cancer is abdominal pain, followed by weight loss, nausea, and vomiting. There are a number of effective…
- Date: October 27, 2022
- Author: Thomas Bretz
- Category: FinancialContent